We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · August 01, 2021

Female Sex Is Associated With Higher Rates of Dermatologic AEs Among Patients With Melanoma Treated With ICIs

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Female Sex Is Associated With Higher Rates of Dermatologic Adverse Events Among Patients With Melanoma Receiving Immune Checkpoint Inhibitor Therapy: A Retrospective Cohort Study
J Am Acad Dermatol 2021 Jul 09;[EPub Ahead of Print], AN Bui, A Bougrine, EI Buchbinder, A Giobbie-Hurder, NR LeBoeuf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading